News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
IASLC Calls to End Stigma Surrounding Lung Cancer Diagnosis
IASLC/X
Nov 10, 2024, 17:47

IASLC Calls to End Stigma Surrounding Lung Cancer Diagnosis

IASLC posted the following on X:

“Lung cancer carries a stigma that can delay diagnosis & negatively impact care quality for pts—regardless of their smoking history. Let’s raise awareness/reduce stigma to promote timely medical consultations & improve outcomes for those affected by lung cancer!”

IASLC Calls to End Stigma Surrounding Lung Cancer Diagnosis

awareness cancer awareness cancer stigma diagnosis delay Healthcare Access IASLC Lung cancer lung cancer outcomes lung cancer patients medical consultations Oncology patient care public health smoking history stigma
Special Coverage
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma
Blog
Apr 4, 2025, 19:34
Matthew Kurian: The barriers to AI adoption in oncology
Blog
Apr 4, 2025, 19:19
Michaela Cada: Proud to be part of the SickKids family for 20 years
Blog
Apr 4, 2025, 19:05
Laurence Albiges: Day 1 of ESMO Preceptorship in metastatic urothelial RCC cancer
Blog
Apr 4, 2025, 18:55
The invisible killer in your lungs - Pink Hearts Cancer Support Foundation
Blog
Apr 4, 2025, 18:54
Yelak Biru: How pharma medical affairs and innovation teams can learn from Myelo’s AI journey
Insight
Apr 4, 2025, 18:36
Luis Lara-Mejía: Neoadjuvant aumolertinib converted 45.1% of unresectable stage III EGFRm NSCLC to resectable status
Insight
Apr 4, 2025, 18:06
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Blog
Apr 4, 2025, 17:45
Raj Batra: The absence of scientific rationale underlying contemporary clinical trials in lung cancers